Research libraryMOLEKUL / SOURCE RECORD

Cortexin in 187 patients with prior brain injury

A. Yu. Emelyanov, A. Yu. Emelin, V. A. Bitsadze, S. V. Surkin, A. A. Bodrug · 2004 · Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table

Indexed 2026-11-09.

Uncontrolled human reportRussian source · see review scopeSource linked

Related evidence maps: Military & occupational ↗

Reported findings and study design

The authors classified 95 outcomes as good and 62 as satisfactory. Thirty were unsatisfactory. Less-severe injuries had more favorable results.

Clinical neurological and psychological testing, EEG and Doppler examinations. No randomized untreated comparison.

Dose, route and schedule

In the parallel text, 10 mg Cortexin intramuscularly daily for 10–20 days.

Protocol source ↗ · Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table

Reported findings and study figures · Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table
MeasureResultComparison, timing and statistics
Good or satisfactory157 of 187 (84.0% from the reported counts)Good: 95; satisfactory: 62; unsatisfactory: 30.
Unsatisfactory by severity8/117 (6.8%) versus 22/70 (31.4%)Less severe versus severe injury.
Cohort scope107 combat injuries within 187 overallThe parallel publication and later dissertation are related sources, with no confirmed independent cohort.

Case-series outcome grading and concurrent rehabilitation do not isolate the effect of Cortexin.

Source for the extracted data ↗ · Checked 2026-11-09

Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.

Methods, limitations & source review

Study limitations

  • Case-series outcome grading and concurrent rehabilitation do not isolate the effect of Cortexin.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Document format: Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table

Review depth: Reported methods, results and evidence limitations

Source access and review scope

Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table

Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.

Source type: Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table

Open original source or index record ↗

Citation and original source

Original source: A. Yu. Emelyanov, A. Yu. Emelin, V. A. Bitsadze, S. V. Surkin, A. A. Bodrug. Cortexin in 187 patients with prior brain injury Bulletin of the Russian Military Medical Academy, 2004(2):74–76; parallel report with outcome table 2004.

Molekul research summary: https://molekul.io/research/emelyanov-cortexin-brain-injury-2004. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards